msJAMA. Genomics in medicine and public health: role of cost-effectiveness analysis

JAMA. 2001 Oct 3;286(13):1637-8.
No abstract available

MeSH terms

  • Cost-Benefit Analysis
  • Genetic Diseases, Inborn / economics*
  • Genetic Diseases, Inborn / prevention & control
  • Genetic Predisposition to Disease
  • Genetic Testing / economics*
  • Humans
  • Preventive Medicine / economics